-
-
-
-
-
-
-
Quoin Pharmaceuticals receives FDA fast track designation for QRX003
-
-
-
-
-
-
-
Quoin Pharmaceuticals Ltd (QNRX) Granted FDA Rare Pediatric Disease Designation for QRX003
-
-
-
-
-
-
-
Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies
-
-
-
-
-
-
-
Quoin Pharmaceuticals Ltd (QNRX) Announces Insider Share Purchases by Co-Founders CEO and COO
-
416,803 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

